• Coronavirus disease 2019 (COVID-19) cases in the U.S. : updated March 20, 2020 Cite CITE Title : Coronavirus disease 2019 (COVID-19) cases in the U.S. : updated March 20, 2020 Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : March 20, 2020 Series : Coronavirus Disease 2019 (CoVID-19) URL : https://stacks.cdc.gov/view/cdc/86064 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2020). Coronavirus disease 2019 (COVID-19) cases in the U.S. : updated March 20, 2020. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Coronavirus disease 2019 (COVID-19) cases in the U.S. : updated March 20, 2020" (2020) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Coronavirus disease 2019 (COVID-19) cases in the U.S. : updated March 20, 2020" , 2020 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 517.96 KB] Corporate Authors: National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. March 20, 2020 | Coronavirus Disease 2019 (CoVID-19) Description: Updated March 20, 2020This page will be updated regularly at noon Mondays through Fridays. Numbers close out at 4 p.m. the day before reporting.CDC is... File Type: [PDF - 517.96 KB] File Type: [PDF - 517.96 KB] Coronavirus disease 2019 (COVID-19) : frequently asked questions Cite CITE Title : Coronavirus disease 2019 (COVID-19) : frequently asked questions Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : March 22, 2020 Series : Coronavirus Disease 2019 (CoVID-19) URL : https://stacks.cdc.gov/view/cdc/86069 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2020). Coronavirus disease 2019 (COVID-19) : frequently asked questions. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Coronavirus disease 2019 (COVID-19) : frequently asked questions" (2020) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Coronavirus disease 2019 (COVID-19) : frequently asked questions" , 2020 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 216.07 KB] Corporate Authors: National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. March 22, 2020 | Coronavirus Disease 2019 (CoVID-19) No Description File Type: [PDF - 216.07 KB] File Type: [PDF - 216.07 KB] Information for clinicians on therapeutic options for COVID-19 patients Cite CITE Title : Information for clinicians on therapeutic options for COVID-19 patients Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : March 21, 2020 Series : Coronavirus Disease 2019 (COVID-19) URL : https://stacks.cdc.gov/view/cdc/86067 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2020). Information for clinicians on therapeutic options for COVID-19 patients. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Information for clinicians on therapeutic options for COVID-19 patients" (2020) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Information for clinicians on therapeutic options for COVID-19 patients" , 2020 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 65.84 KB] Corporate Authors: National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. March 21, 2020 | Coronavirus Disease 2019 (COVID-19) Description: There are no US Food and Drug Administration (FDA)-approved drugs specifically for the treatment of patients with COVID-19. At present clinical manage... File Type: [PDF - 65.84 KB] File Type: [PDF - 65.84 KB] Coronavirus disease 2019 (COVID-19) situation summary updated March 21, 2020 Cite CITE Title : Coronavirus disease 2019 (COVID-19) situation summary updated March 21, 2020 Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : March 21, 2020 Series : Coronavirus Disease 2019 (COVID-19) URL : https://stacks.cdc.gov/view/cdc/86068 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2020). Coronavirus disease 2019 (COVID-19) situation summary updated March 21, 2020. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Coronavirus disease 2019 (COVID-19) situation summary updated March 21, 2020" (2020) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Coronavirus disease 2019 (COVID-19) situation summary updated March 21, 2020" , 2020 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 346.12 KB] Corporate Authors: National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. March 21, 2020 | Coronavirus Disease 2019 (COVID-19) Description: This is an emerging, rapidly evolving situation and CDC will provide updated information as it becomes available, in addition to updated guidance.Upda... File Type: [PDF - 346.12 KB] File Type: [PDF - 346.12 KB] Coronavirus Disease 2019 (COVID-19) testing in the U.S. : updated March 21, 2020 Cite CITE Title : Coronavirus Disease 2019 (COVID-19) testing in the U.S. : updated March 21, 2020 Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : March 21, 2020 Series : Coronavirus Disease 2019 (CoVID-19) URL : https://stacks.cdc.gov/view/cdc/86066 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2020). Coronavirus Disease 2019 (COVID-19) testing in the U.S. : updated March 21, 2020. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Coronavirus Disease 2019 (COVID-19) testing in the U.S. : updated March 21, 2020" (2020) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Coronavirus Disease 2019 (COVID-19) testing in the U.S. : updated March 21, 2020" , 2020 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 539.17 KB] Corporate Authors: National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. March 21, 2020 | Coronavirus Disease 2019 (CoVID-19) Description: This page will be updated regularly at noon Mondays through Fridays. Data close out at 4 p.m. the day before reporting.CDC is responding to an outbrea... File Type: [PDF - 539.17 KB] File Type: [PDF - 539.17 KB] Coronavirus Disease 2019 (COVID-19) testing in the U.S. : updated March 20, 2020 Cite CITE Title : Coronavirus Disease 2019 (COVID-19) testing in the U.S. : updated March 20, 2020 Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : March 20, 2020 Series : Coronavirus Disease 2019 (CoVID-19) URL : https://stacks.cdc.gov/view/cdc/86063 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2020). Coronavirus Disease 2019 (COVID-19) testing in the U.S. : updated March 20, 2020. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Coronavirus Disease 2019 (COVID-19) testing in the U.S. : updated March 20, 2020" (2020) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Coronavirus Disease 2019 (COVID-19) testing in the U.S. : updated March 20, 2020" , 2020 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 542.80 KB] Corporate Authors: National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. March 20, 2020 | Coronavirus Disease 2019 (CoVID-19) Description: This page will be updated regularly at noon Mondays through Fridays. Data close out at 4 p.m. the day before reporting.CDC is responding to an outbrea... File Type: [PDF - 542.80 KB] File Type: [PDF - 542.80 KB] CDC protects and prepares communities Cite CITE Title : CDC protects and prepares communities Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : 03/18/2020 Series : Coronavirus Disease 2019 (CoVID-19) URL : https://stacks.cdc.gov/view/cdc/86061 Centers for Disease Control and Prevention (U.S.) (2020). CDC protects and prepares communities. Centers for Disease Control and Prevention (U.S.) "CDC protects and prepares communities" (2020) Centers for Disease Control and Prevention (U.S.) "CDC protects and prepares communities" , 2020 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 813.54 KB] Corporate Authors: Centers for Disease Control and Prevention (U.S.) 03/18/2020 | Coronavirus Disease 2019 (CoVID-19) Description: CDC is aggressively responding to the global outbreak of COVID-19 and community spread in the U.S.cdc.gov/COVID19CS 315454-Ainfographic-cdc-protects-5... File Type: [PDF - 813.54 KB] File Type: [PDF - 813.54 KB] Coronavirus Disease 2019 (COVID-19) world map : global map as of 12:00 p.m. ET March 21, 2020 Cite CITE Title : Coronavirus Disease 2019 (COVID-19) world map : global map as of 12:00 p.m. ET March 21, 2020 Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : March 21, 2020 Series : Coronavirus Disease 2019 (CoVID-19) URL : https://stacks.cdc.gov/view/cdc/86065 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2020). Coronavirus Disease 2019 (COVID-19) world map : global map as of 12:00 p.m. ET March 21, 2020. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Coronavirus Disease 2019 (COVID-19) world map : global map as of 12:00 p.m. ET March 21, 2020" (2020) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Coronavirus Disease 2019 (COVID-19) world map : global map as of 12:00 p.m. ET March 21, 2020" , 2020 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 539.17 KB] Corporate Authors: National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. March 21, 2020 | Coronavirus Disease 2019 (CoVID-19) No Description File Type: [PDF - 539.17 KB] File Type: [PDF - 539.17 KB] Coronavirus Disease 2019 (COVID-19) world map : global map as of 12:00 p.m. ET March 20, 2020 Cite CITE Title : Coronavirus Disease 2019 (COVID-19) world map : global map as of 12:00 p.m. ET March 20, 2020 Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Published Date : March 20, 2020 Series : Coronavirus Disease 2019 (CoVID-19) URL : https://stacks.cdc.gov/view/cdc/86062 National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. (2020). Coronavirus Disease 2019 (COVID-19) world map : global map as of 12:00 p.m. ET March 20, 2020. National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Coronavirus Disease 2019 (COVID-19) world map : global map as of 12:00 p.m. ET March 20, 2020" (2020) National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. "Coronavirus Disease 2019 (COVID-19) world map : global map as of 12:00 p.m. ET March 20, 2020" , 2020 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 224.26 KB] Corporate Authors: National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. March 20, 2020 | Coronavirus Disease 2019 (CoVID-19) No Description File Type: [PDF - 224.26 KB] File Type: [PDF - 224.26 KB] CDC致力保护社区并协助做好抗疫准备工作 Cite CITE Title : CDC致力保护社区并协助做好抗疫准备工作 Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : 03/18/2020 Series : Coronavirus Disease 2019 (CoVID-19) URL : https://stacks.cdc.gov/view/cdc/86059 Centers for Disease Control and Prevention (U.S.) (2020). CDC致力保护社区并协助做好抗疫准备工作. Centers for Disease Control and Prevention (U.S.) "CDC致力保护社区并协助做好抗疫准备工作" (2020) Centers for Disease Control and Prevention (U.S.) "CDC致力保护社区并协助做好抗疫准备工作" , 2020 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 884.64 KB] Corporate Authors: Centers for Disease Control and Prevention (U.S.) 03/18/2020 | Coronavirus Disease 2019 (CoVID-19) Description: CDC protects and prepares communities [Chinese]CDC正在积极应对全球COVID-19的爆发以及美国境内的社区传播。cdc.gov/COVID19CS 31545... File Type: [PDF - 884.64 KB] File Type: [PDF - 884.64 KB] Los CDC protegen y preparan a las comunidades Cite CITE Title : Los CDC protegen y preparan a las comunidades Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : 03/18/2020 Series : Coronavirus Disease 2019 (CoVID-19) URL : https://stacks.cdc.gov/view/cdc/86060 Centers for Disease Control and Prevention (U.S.) (2020). Los CDC protegen y preparan a las comunidades. Centers for Disease Control and Prevention (U.S.) "Los CDC protegen y preparan a las comunidades" (2020) Centers for Disease Control and Prevention (U.S.) "Los CDC protegen y preparan a las comunidades" , 2020 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 822.75 KB] Corporate Authors: Centers for Disease Control and Prevention (U.S.) 03/18/2020 | Coronavirus Disease 2019 (CoVID-19) Description: CDC protects and prepares communities [Spanish]Los CDC están respondiendo enérgicamente al brote mundial de COVID-19 y su propagación comunitari... File Type: [PDF - 822.75 KB] File Type: [PDF - 822.75 KB] CDC protects and prepares communities [Korean] Cite CITE Title : CDC protects and prepares communities [Korean] Corporate Authors(s) : Centers for Disease Control and Prevention (U.S.) Published Date : 03/18/2020 Series : Coronavirus Disease 2019 (CoVID-19) URL : https://stacks.cdc.gov/view/cdc/86058 Centers for Disease Control and Prevention (U.S.) (2020). CDC protects and prepares communities [Korean]. Centers for Disease Control and Prevention (U.S.) "CDC protects and prepares communities [Korean]" (2020) Centers for Disease Control and Prevention (U.S.) "CDC protects and prepares communities [Korean]" , 2020 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 835.13 KB] Corporate Authors: Centers for Disease Control and Prevention (U.S.) 03/18/2020 | Coronavirus Disease 2019 (CoVID-19) Description: CDC protects and prepares communities [Korean]CDC is aggressively responding to the global outbreak of COVID-19 and community spread in the U.S. [Kore... File Type: [PDF - 835.13 KB] File Type: [PDF - 835.13 KB] ToxFAQs™ - 2-Hexanona (2-Hexanone) Cite CITE Title : ToxFAQs™ - 2-Hexanona (2-Hexanone) Corporate Authors(s) : United States. Agency for Toxic Substances and Disease Registry. Division of Toxicology and Human Health.;SRC, Inc.; Published Date : Septiembre 1995 Series : ToxFAQs URL : https://stacks.cdc.gov/view/cdc/86053 United States. Agency for Toxic Substances and Disease Registry. Division of Toxicology and Human Health. (1995). ToxFAQs™ - 2-Hexanona (2-Hexanone). United States. Agency for Toxic Substances and Disease Registry. Division of Toxicology and Human Health. "ToxFAQs™ - 2-Hexanona (2-Hexanone)" (1995) United States. Agency for Toxic Substances and Disease Registry. Division of Toxicology and Human Health. "ToxFAQs™ - 2-Hexanona (2-Hexanone)" , 1995 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 178.71 KB] Corporate Authors: United States. Agency for Toxic Substances and Disease Registry. Division of Toxicology and Human Health. ... Septiembre 1995 | ToxFAQs Description: 2-Hexanone - ToxFAQs [Spanish]La 2-hexanona se conoce también como metil n-butil cetona (MBK) o propil acetona. Es un líquido incoloro de aroma pene... File Type: [PDF - 178.71 KB] File Type: [PDF - 178.71 KB] 2-Hexanone - ToxFAQs Cite CITE Title : 2-Hexanone - ToxFAQs Corporate Authors(s) : United States. Agency for Toxic Substances and Disease Registry. Division of Toxicology and Human Health.;SRC, Inc.; Published Date : February 2020 Series : ToxFAQs URL : https://stacks.cdc.gov/view/cdc/86054 United States. Agency for Toxic Substances and Disease Registry. Division of Toxicology and Human Health. (2020). 2-Hexanone - ToxFAQs. United States. Agency for Toxic Substances and Disease Registry. Division of Toxicology and Human Health. "2-Hexanone - ToxFAQs" (2020) United States. Agency for Toxic Substances and Disease Registry. Division of Toxicology and Human Health. "2-Hexanone - ToxFAQs" , 2020 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 170.47 KB] Corporate Authors: United States. Agency for Toxic Substances and Disease Registry. Division of Toxicology and Human Health. ... February 2020 | ToxFAQs Description: 2-Hexanone is also known as methyl n-butyl ketone, MBK, or propyl acetone. It is a clear, colorless liquid with a sharp odor. It dissolves very easily... File Type: [PDF - 170.47 KB] File Type: [PDF - 170.47 KB]

More +